Variant | Gene | Disease | Risk Allele | Score vda | Association Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
T | 0.800 | GeneticVariation | CLINVAR | Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF. | 15035987 | 2004 |
|||||||
|
|
G | 0.800 | GeneticVariation | CLINVAR | Prospective enterprise-level molecular genotyping of a cohort of cancer patients. | 25157968 | 2014 |
|||||||
|
|
C | 0.780 | GeneticVariation | CLINVAR | Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF. | 15035987 | 2004 |
|||||||
|
|
T | 0.780 | GeneticVariation | CLINVAR | Prospective enterprise-level molecular genotyping of a cohort of cancer patients. | 25157968 | 2014 |
|||||||
|
|
T | 0.780 | GeneticVariation | CLINVAR | Prospective enterprise-level molecular genotyping of a cohort of cancer patients. | 25157968 | 2014 |
|||||||
|
|
T | 0.780 | GeneticVariation | CLINVAR | p53 regulates glucose metabolism through an IKK-NF-kappaB pathway and inhibits cell transformation. | 18391940 | 2008 |
|||||||
|
|
T | 0.780 | GeneticVariation | CLINVAR | Role of the p53-homologue p73 in E2F1-induced apoptosis. | 11101847 | 2000 |
|||||||
|
|
T | 0.770 | GeneticVariation | CLINVAR | Mutant p53 in cancer: new functions and therapeutic opportunities. | 24651012 | 2014 |
|||||||
|
|
T | 0.770 | GeneticVariation | CLINVAR | Prospective enterprise-level molecular genotyping of a cohort of cancer patients. | 25157968 | 2014 |
|||||||
|
|
A | 0.760 | GeneticVariation | CLINVAR | Prospective enterprise-level molecular genotyping of a cohort of cancer patients. | 25157968 | 2014 |
|||||||
|
|
A | 0.740 | GeneticVariation | CLINVAR | Prospective enterprise-level molecular genotyping of a cohort of cancer patients. | 25157968 | 2014 |
|||||||
|
|
T | 0.740 | GeneticVariation | CLINVAR | Prospective enterprise-level molecular genotyping of a cohort of cancer patients. | 25157968 | 2014 |
|||||||
|
|
T | 0.740 | GeneticVariation | CLINVAR | Structural basis for understanding oncogenic p53 mutations and designing rescue drugs. | 17015838 | 2006 |
|||||||
|
|
C | 0.730 | GeneticVariation | CLINVAR | Prospective enterprise-level molecular genotyping of a cohort of cancer patients. | 25157968 | 2014 |
|||||||
|
|
G | 0.730 | GeneticVariation | CLINVAR | Prospective enterprise-level molecular genotyping of a cohort of cancer patients. | 25157968 | 2014 |
|||||||
|
|
A | 0.730 | GeneticVariation | CLINVAR | Prospective enterprise-level molecular genotyping of a cohort of cancer patients. | 25157968 | 2014 |
|||||||
|
|
G | 0.730 | GeneticVariation | CLINVAR | Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF. | 15035987 | 2004 |
|||||||
|
|
A | 0.730 | GeneticVariation | CLINVAR | Prospective enterprise-level molecular genotyping of a cohort of cancer patients. | 25157968 | 2014 |
|||||||
|
|
T | 0.730 | GeneticVariation | CLINVAR | GNAS-activating mutations define a rare subgroup of inflammatory liver tumors characterized by STAT3 activation. | 21835143 | 2012 |
|||||||
|
|
A | 0.730 | GeneticVariation | CLINVAR | GNAS-activating mutations define a rare subgroup of inflammatory liver tumors characterized by STAT3 activation. | 21835143 | 2012 |
|||||||
|
|
T | 0.730 | GeneticVariation | CLINVAR | An orally available small-molecule inhibitor of c-Met, PF-2341066, exhibits cytoreductive antitumor efficacy through antiproliferative and antiangiogenic mechanisms. | 17483355 | 2007 |
|||||||
|
|
T | 0.720 | GeneticVariation | CLINVAR | Prospective enterprise-level molecular genotyping of a cohort of cancer patients. | 25157968 | 2014 |
|||||||
|
|
T | 0.720 | GeneticVariation | CLINVAR | Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF. | 15035987 | 2004 |
|||||||
|
|
A | 0.720 | GeneticVariation | CLINVAR | Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF. | 15035987 | 2004 |
|||||||
|
|
T | 0.720 | GeneticVariation | CLINVAR | An orally available small-molecule inhibitor of c-Met, PF-2341066, exhibits cytoreductive antitumor efficacy through antiproliferative and antiangiogenic mechanisms. | 17483355 | 2007 |